Search General Info
Search Education
Search Partnering Companies

Steve Carney

Richmond, United Kingdom
Steve Carney was born in Liverpool, England and studied Biochemistry at Liverpool University, obtaining a BSc.(Hons) and then read for a PhD on the Biochemistry and Pathology of Connective Tissue Diseases in Manchester University, in the Departments of Medical Biochemistry and Histopathology. On completion of his PhD he moved to the Kennedy Institute of Rheumatology, London, where he worked with Professor Helen Muir FRS and Professor Tim Hardingham, on the biochemistry of experimental Osteoarthritis, a position initially funded by ICI pharmaceuticals. He joined Eli Lilly and Co. and held a number of positions in Biology R&D, initially in the Connective Tissue Department, but latterly in the Neuroscience Department. He left Lilly to take up his present position as Editor-in-Chief, Drug Discovery Today, at Elsevier. Currently, he also holds an honorary lectureship in Drug Discovery at the University of Surrey, UK. He has authored over 50 articles in peer-reviewed journals, written several book chapters and has held a number of patents.
Speaking In
2:30 PM - 3:25 PM (PDT)
Wednesday, June 10
Applying digital technologies in R&D is estimated to represent a $100 billion opportunity. Much of…
[Available On-Demand]
The CNS drug field has been hampered by trial failures in areas of substantial unmet medical need…